Clinical Trial Update: Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating lenalidomide as initial treatment in older patients with chronic lymphocytic leukemia; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, CLL | Phase 2 | Status: COMPLETED | Results posted: 2013-09-02